AbbVie

Yahoo Finance • 17 days ago

John Rogers' Strategic Moves: A Closer Look at Royal Caribbean Group's Impact

Exploring the Latest 13F Filing and Key Investment Adjustments John Rogers (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2024, providing insights into his investment moves during this period. John Rogers... Full story

Yahoo Finance • 18 days ago

AbbVie Declares Quarterly Dividend

NORTH CHICAGO, Ill., Feb. 13, 2025 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.64 per share. The cash dividend is payable May 15, 2025, to stockholders of record at the... Full story

Yahoo Finance • 19 days ago

AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies

Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, including masked T-cell engagersXilio to host investor conference call and webcast today at 8:30 a... Full story

Yahoo Finance • 22 days ago

3 Fabulous Dividend Stocks to Buy in February

February is the shortest month, but that doesn't mean income investors don't have much time to find great stocks. Three Motley Fool contributors believe they have identified fabulous dividend stocks to buy this month. Here's why they like... Full story

Yahoo Finance • 22 days ago

68-Year-Old Earning $4,300/Month in Dividends Shares His Top 7 Stock Picks — 'Dividends Have Been Consistent, Stable'

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. U.S. markets were seeing volatility as technology earnings began to worry investors due to soft forecasts and mounting AI-related expense... Full story

Yahoo Finance • 24 days ago

3 US Stocks Estimated To Be Undervalued For Savvy Investors

As the U.S. market hovers near record highs, investors are closely monitoring the upcoming January jobs report for insights into economic health and interest rate trends. In this environment, identifying stocks that may be undervalued can... Full story

Yahoo Finance • 25 days ago

3 Stocks That Investors Might Be Undervaluing By Up To 43.3%

In the current global market landscape, investors are navigating a complex environment marked by fluctuating interest rates, geopolitical tensions, and volatile corporate earnings. With U.S. stocks experiencing a mixed performance and Euro... Full story

Yahoo Finance • last month

If You Invested $10,000 In AbbVie Stock 10 Years Ago, How Much Would You Have Now?

If You Invested $10,000 In AbbVie Stock 10 Years Ago, How Much Would You Have Now? Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. AbbVie Inc. (NYSE:ABBV) discovers, develops, manufact... Full story

Yahoo Finance • last month

Is AbbVie Inc. (ABBV) The Best Bear Market Stock To Invest In Now?

We recently published a list of 11 Best Bear Market Stocks To Invest In Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best bear market stocks to invest in now. As of January 2025,... Full story

Yahoo Finance • last month

Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever

You've probably heard this before: Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the case? These companies make drugs doctors and patients rely on -- and that means no matter what the economy is doing,... Full story

Yahoo Finance • last month

Top Wall Street Analyst Says Dump The Magnificent 7 And Go All In On These Three Big Pharma Dividend Stocks

Top Wall Street Analyst Says Dump The Magnificent 7 And Go All In On These Three Big Pharma Dividend Stocks Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. 2024 was a great year for in... Full story

Yahoo Finance • 4 months ago

BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)

The Only Product of Its Kind Approved for Use in Four Aesthetic Indications: Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines, Frown Lines, Crow's Feet Lines, and Now Platysma Bands in Adults1-5 With this Approv... Full story

Yahoo Finance • 5 months ago

U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease

VYALEV™ is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's disease Adults treated with VYALEV reported superior improvement in "on" time... Full story

Yahoo Finance • 5 months ago

Dividend Investor Who 'Doubled' His Passive Income to $1,000 a Month in Six Months Reveals Portfolio: Top 8 High-Yield Stocks

Dividend Investor Who 'Doubled' His Passive Income to $1,000 a Month in Six Months Reveals Portfolio: Top 8 High-Yield Stocks Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As enthusi... Full story

Yahoo Finance • 5 months ago

Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade

The major U.S. stock market indexes are officially in overheated territory thanks to enthusiasm for artificial intelligence (AI). Since the end of 2022, the most popular benchmark, the S&P 500 index, has soared about 51% to a rich valuatio... Full story

Yahoo Finance • 5 months ago

Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal

Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal Blue Shield of California is shaking up the pharmacy landscape with a landmark deal to drastically reduce the price of a biosimilar alternative to AbbVie Inc.’s (... Full story

Yahoo Finance • 5 months ago

AbbVie Inc. (ABBV) Projects Mid-Single-Digit Sales Growth Over Next 3 Years

We recently published a list of 8 Best Inexpensive Stocks To Invest In Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other best inexpensive stocks to invest in now. Are Experts Alrea... Full story

Yahoo Finance • 5 months ago

15 Best Dividend Stocks for Lifelong Passive Income

Dividend stocks offer a path to steady passive income, but not all are created equal. The key to long-term success lies in dividend sustainability, not just high current yields. The payout ratio serves as a critical tool for assessing sus... Full story

Yahoo Finance • 5 months ago

Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential

Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential On Thursday, the FDA approved Bristol Myers Squibb & Co’s (NYSE:BMY) Cobenfy (xanomeline and trospium chloride, KarXT),... Full story

Yahoo Finance • 5 months ago

AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer

- Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression. - Biologics License Application (BLA) submission for acc... Full story